HOTAIR is overexpressed in ovarian cancer, and it is associated with stage, lymph node metastases and poor survival [120]; similarly, HOTAIR is overexpressed in cervical cancer [121,122] and in endometrial carcinoma [123] in which it is also associated with cisplatin resistance acquisition [124]. Here, HOTAIR is linked to ovarian cancer.